<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?</p></abstract>

Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the metabolic health beneficial products of the adipose tissue. Nevertheless, adiponectin has been shown to exert some extra beneficial non metabolic actions, as well. Adiponectin levels can be related to reduced incidence of cancer in obese patients. Moreover, adiponectin has been shown to be implicated in the positive fertility outcomes of women. Some new studies have also indicated that adiponectin has a potential effect in the control of appetite, which raises a question, whether adiponectin could be accredited to be useful in the endocrine evaluation of obesity. Could these additional non-metabolic actions prove its helpfulness?

Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Endocrine Regulations

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Adiponectin is a hormone secreted by adipose tissue, exerting many positive effects in the human body. Its action has been widely studied, placing it into the...

Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Online veröffentlicht: 27. Aug. 2020

Seitenbereich: 157 - 159

DOI: https://doi.org/10.2478/enr-2020-0018

Schlüsselwörter
adiponectin, obesity, non metabolic actions

© 2020 Konstantinos G. Michalakis, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Endocrine approach in the treatment of obesity: Is there any space for the adiponectin action?

Online veröffentlicht: 27. Aug. 2020

Seitenbereich: 157 - 159

DOI: https://doi.org/10.2478/enr-2020-0018

Schlüsselwörteradiponectin, obesity, non metabolic actions

© 2020 Konstantinos G. Michalakis, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Schlüsselwörter
adiponectin, obesity, non metabolic actions